-
Neurology: Mechanisms of beta-amyloidosis implicated in Alzheimer's disease, dementia with Lewy
Time of Update: 2022-02-20
Since cortical atrophy can reflect the pathological spreading pattern of AD and LBD, a comparative assessment of the cortical thinning pattern associated with cholinergic atrophy and beta-amyloid burden is helpful in understanding these two most common neurodegenerative diseases .
-
Restoring normal sleep reduces the accumulation of beta amyloid in a mouse model of Alzheimer's disease
Time of Update: 2021-11-11
Jagirdar said: "By testing 6 to 7-month-old mice, we assessed whether the sleep fragmentation and slow-wave sleep reduction we observed in the AD mouse model are related to the accumulation of late a-β .
-
Alzheimer's & Dementia: The relationship between walking energy expenditure and amyloid beta status: Findings from the Baltimore Longitudinal Study on Aging
Time of Update: 2021-09-03
Recently, researchers investigated the cross-sectional relationship between the energy cost of walking, gait speed, and amyloid beta (Aβ) status (+/-) in elderly people .
Researchers investigated the cross-sectional relationship between the energy cost of walking, gait speed, and amyloid beta (Aβ) status (+/-) in elderly people.
-
Journal of Science: Relationship between natural A-beta antibodies and alzheimer's brain amyloid and cognitive function
Time of Update: 2021-01-16
Alzheimer's disease (AD), commonly known as Alzheimer's disease, is a de-detox. early stages, AD is characterized by aggregation and memory loss of amyloid β (A beta) and tau proteins in the brain.
-
Alzheimer's is studying drug inventory: from anti-beta amyloid to gene therapy!
Time of Update: 2020-10-04
At the same time, South Korea's AriBio is developing AR1001, an orally active PDE-5 inhibitor that increases the removal of toxic A-beta oligomers from the blood, but is also thought to inhibit neuron cell death and restore synapses lost in AD, which entered the phase 2 clinical treatment of mild to moderate AD last year.
-
Alzheimer's (AD) overweight pounds! Yan Jian/Weiwood beta amyloid antibody aducanumab by the U.S. FDA priority review, accelerated approval!
Time of Update: 2020-08-27
If approved, aducanumab will be the first treatment that has the potential to meaningfully change the AD process and slow the decline of AD clinical conditions, and the first to demonstrate that removing beta amyloid (A beta) can achieve better clinical outcomes." AD is one of today's biggest public health challenges, resulting in patients gradually losing their memory and ability to live independently, ultimately depriving them of basic behavior.
-
Alzheimer's (AD) big news! YanJian/Aishiau beta amyloid antibody aducanumab in the United States to complete the listing application submission!
Time of Update: 2020-07-14
Biogen and partner Eisai have jointly announced that they have completed a Bioproduct License Application (BLA) with the U.S Food and Drug Administration (FDA) to seek approval for the drug aducanum
-
Study reveals beta-amyloid polymer structure that causes Alzheimer's disease development
Time of Update: 2020-06-08
"About 10 percent of Alzheimer's cases are caused by family mutations," said Wei Qiang, assistant professor of biophysical chemistry at Binghamton University Another 90% of cases were caused by improp
-
Alzheimer's preventive trial DIAN-TU beta-amyloid hypothesis the final straw?
Time of Update: 2020-06-02
The beta-amyloid hypothesis is considered to be one of the mechanisms of Alzheimer's disease, but many clinical trials have been falsifying the proposition that from 2012 to 2019, almost every two yea
-
Amyloid beta is the cause of Alzheimer's disease!
Time of Update: 2020-01-30
In a new preclinical study, researchers from the University of Alabama, Birmingham, found an important missing part of Alzheimer's disease This makes it possible to carry out concept verification expe
-
Science: amyloid beta is the cause of Alzheimer's disease! It hijacks norepinephrine signals to activate the pathological GSK3 β / tau cascade
Time of Update: 2020-01-22
January 22, 2020 / Biovalley BIOON / - -- in a new preclinical study, researchers from the University of Alabama, Birmingham, found an important missing part of Alzheimer's disease This makes it possi
